本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kazia Therapeutics Limited

6.27
-1.0200-13.99%
成交量:7.02万
成交额:46.69万
市值:1,047.47万
市盈率:-0.51
高:7.12
开:7.11
低:6.27
收:7.29
52周最高:30.05
52周最低:2.86
股本:167.06万
流通股本:147.79万
量比:2.96
换手率:4.75%
股息:- -
股息率:- -
每股收益(TTM):-12.3910
每股收益(LYR):-12.3910
净资产收益率:-3891.64%
总资产收益率:-63.96%
市净率:-1.94
市盈率(LYR):-0.51

数据加载中...

2025/11/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/09/30

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/02/03

SEC问询函

Form CORRESP - Correspondence
2025/01/30

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/11/15

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/08/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/03

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

SEC问询函

Form CORRESP - Correspondence
2024/06/25

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/06/01

SEC问询函

Form CORRESP - Correspondence
2024/05/29

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/03

SEC问询函

Form CORRESP - Correspondence
2024/01/31

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/12/21

SEC问询函

Form CORRESP - Correspondence
2023/10/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/20

SEC问询函

CORRESP [Cover] - Correspondence